This study highlights that engineering antibodies to reduce neonatal Fc receptor interactions, combined with focused ultrasound-induced blood–brain barrier disruption, can improve the quantitative imaging of PD-L1 expression in glioblastoma. The gene discussed is CD274; the disease is glioblastoma.